注射薬物送達の世界市場の収益分析:機器別(自己注射機器、従来の機器)、処方別(従来型薬物送達、新規型薬物送達)、治療使用方法別(自己免疫疾患、ホルモン障害、腫瘍学)、エンドユーザー用途別(病院、ホームケア施設、研究機関、臨床検査室)、地域別(アメリカ、カナダ、ドイツ、英国、中国、インド、南アフリカ、サウジアラビア、ブラジル、メキシコ)、セグメント予測、2013-2024...市場調査レポートについてご紹介

【英文タイトル】Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user Application (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region (U.S, Canada, Germany, U.K, China, India, South Africa, Saudi Arabia, Brazil, Mexico) And Segment Forecasts From 2013 to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Injectable drug delivery market – Industry Summary and Key Buying Criteria, 2013 – 2024
Chapter 3. Injectable Drug DeliveryIndustry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2013 – 2024
3.3. Injectable drug delivery: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Escalation in demand for self- injection devices
3.3.1.2. Increase in number of chronic diseases
3.3.1.3. Innovative technological progress
3.3.1.4. Development of the biologics market
3.3.2. Market restraint analysis
3.3.2.1. Needle stick injuries and infections
3.3.2.2. Preference over other drug delivery systems
3.3.2.3. Sterility of injectables
3.4. Injectable drug delivery market: Industry trend analysis
3.5. Injectable drug delivery market – PESTEL Analysis
3.6. Injectable drug delivery Industry analysis – Porter’s Five Forces Model
3.7. Injectable drug delivery: Company Market Share Analysis (%), 2015
3.8. Key opportunities prioritized
Chapter 4. Injectable Drug Delivery Product Type Outlook
4.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Product Outlook, 2016 & 2024
4.2. By Devices
4.2.1. Self-injection devices
4.2.1.1. Self-injection devices market revenue, by region, 2013 to 2024 (USD Million)
4.2.2. Conventional devices
4.2.2.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3. By Formulations
4.3.1. Conventional drug delivery
4.3.1.1. Conventional drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.3.2. Novel drug delivery
4.3.2.1. Novel drug delivery market revenue, by region, 2013 to 2024 (USD Million)
4.4. Others
4.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 5. Injectable Drug Delivery Therapeutic Use Outlook
5.1. Injectable Drug Delivery Revenue Share (%) Analysis, by Therapeutic Use Outlook, 2016& 2024
5.2. Autoimmune disorders
5.2.1. Autoimmune disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.3. Hormonal disorders
5.3.1. Hormonal disorders injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.4. Oncology
5.4.1. Oncology injectable drug delivery market, by region, 2013 to 2024 (USD Million)
5.5. Others
5.5.1. Others drug injectable drug delivery market, by region, 2013 to 2024 (USD Million)
Chapter 6. Injectable Drug Delivery End-User Application Outlook
6.1. Injectable Drug Delivery Revenue Share (%) Analysis, by End-User Application, 2016& 2024
6.2. Hospital
6.2.1. Hospital market revenue, by region, 2013 to 2024 (USD Million)
6.3. Homecare Settings
6.3.1. Homecare settings market revenue, by region, 2013 to 2024 (USD Million)
6.4. Others
6.4.1. Others market revenue, by region, 2013 to 2024 (USD Million)
Chapter 7. Injectable Drug Delivery Regional Outlook
7.1. Injectable drug delivery Market Share (%) Analysis, by Region, 2013&2024
7.2. North America
7.2.1. U.S.
7.2.1.1. U.S. injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.1.2. U.S injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.1.3. U.S. injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.2.1.4. U.S. injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.2.2. Canada
7.2.2.1. Canada injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.2.2.2. Canada injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.2.2.3. Canada injectable drug delivery market, by therapeutic use,2013 – 2024 (USD Million)
7.2.2.4.Canada injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3. Europe
7.3.1. Germany
7.3.1.1. Germany injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.1.2. Germany injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.3.1.3. Germany injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.1.4. Germany injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.3.2. UK
7.3.2.1. UK injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.3.2.2. UK injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.3.2.3. UK injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.3.2.4. UK injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4. Asia-Pacific
7.4.1. China
7.4.1.1. China injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.1.2. China injectable drug delivery market by formulation, 2013 – 2024 (USD Million)
7.4.1.3. China injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.4.1.4. China injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.4.2. India
7.4.2.1. India injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.4.2.2. India injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.4.2.3. India injectable drug delivery market, by therapeutic use 2013 – 2024 (USD Million)
7.4.2.4. India injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.5. MEA
7.5.1. South Africa
7.5.1.1. South Africa injectable drug delivery market, by device, 2012 – 2024 (USD Million)
7.5.1.2. South Africa injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.1.3. South Africa injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.1.4. South Africa injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.5.2. Saudi Arabia
7.5.2.1. Saudi Arabia injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.5.2.2. Saudi Arabia injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.5.2.3. Saudi Arabia injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.5.2.4. Saudi Arabia injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Brazil injectable drug delivery market, by device, 2013 – 2024 (USD Million)
7.6.1.2. Brazil injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.1.3. Brazil injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.1.4. Brazil injectable drug deliverymarket, by end-user application, 2013 – 2024 (USD Million)
7.6.2. Mexico
7.6.2.1. Mexico injectable drug delivery market, by device,2013 – 2024 (USD Million)
7.6.2.2. Mexico injectable drug delivery market, by formulation, 2013 – 2024 (USD Million)
7.6.2.3. Mexico injectable drug delivery market, by therapeutic use, 2013 – 2024 (USD Million)
7.6.2.4. Mexico injectable drug delivery market, by end-user application, 2013 – 2024 (USD Million)
Chapter 8. Competitive Landscape
8.1. Pfizer, Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Baxter International, Inc.
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Schott AG
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Becton, Dickinson and Company
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. ELI Lily and Company
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Alkermes PLC
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Terumo Corporation
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8 Elcam Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9 Unilife Corporation
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:注射薬物送達の世界市場の収益分析:機器別(自己注射機器、従来の機器)、処方別(従来型薬物送達、新規型薬物送達)、治療使用方法別(自己免疫疾患、ホルモン障害、腫瘍学)、エンドユーザー用途別(病院、ホームケア施設、研究機関、臨床検査室)、地域別(アメリカ、カナダ、ドイツ、英国、中国、インド、南アフリカ、サウジアラビア、ブラジル、メキシコ)、セグメント予測、2013-2024
■ 英文:Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user Application (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region (U.S, Canada, Germany, U.K, China, India, South Africa, Saudi Arabia, Brazil, Mexico) And Segment Forecasts From 2013 to 2024
■ 発行日:2016年8月11日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707435
■ 調査対象地域:グローバル
  • 半導体マイクロ部品の世界市場2017-2021:マイクロプロセッサ、マイクロコントローラ、DSP
    About Semiconductor Micro Components Semiconductor micro components are an important part of all the electronic devices. Their adoption is directly proportional to the number of electronic devices being sold. The increased popularity of IoT has led to the need of powerful electronics, which in turn has led to the demand for powerful processors. Local processing capability is most often provided by …
  • ムコ多糖症II型(MPS II)(ハンター症候群)(Mucopolysaccharidosis II (Hunter Syndrome)):治療薬開発パイプライン動向(2015年上半期版)
    Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H1 2015’, provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosi …
  • 銅の世界市場2018-2022
    About this market The increasing demand for EVs and hybrid vehicles to drive growth in the copper market. EVs and hybrid vehicles use twice as much copper, in the form of copper pipes and tubes, as compared to conventional vehicles. Technavio’s analysts have predicted that the copper market will register a CAGR of over 3% by 2022. Market Overview High demand from APAC Copper was among the most con …
  • 世界のエアフィルター市場動向:Global Air Filter Market 2014-2018
    TechNavio's analysts forecast the Global Air Filter market to grow at a CAGR of 4.95 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand from the APAC region. The Global Air Filter market has also been witnessing the increase in partnerships. However, the threat of rivalry could pose a challenge to the growth of this market. TechNav …
  • パウチ包装機械の世界市場2018-2022
    About this market With the advancement of technologies and rising adoption of automation, various pouch packaging machinery market players are equipping their machines with integrated counters. Benefits including the reduced energy consumption and minimal time required for production are expected to aid the pouch packaging machinery market to register a CAGR of more than 5% by 2022. Market Overvie …
  • MOL Hungarian Oil and Gas Public Limited Company:石油・ガスバリューチェーン分析レポート2013
    MOL Hungarian Oil and Gas Public Limited Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "MOL Hungarian Oil and Gas Public Limited Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “MOL Hungarian Oil and Gas Public Limited Company”. The report provides key information relating to oil and gas ass …
  • フレキシブル内視鏡の世界市場:フレキシブルビデオスコープ、フレキシブルファイバースコープ
    About flexible endoscopes Flexible endoscopes consist of a flexible insertion tube equipped with fiber-optic glass rods, camera, and ports that allow a physician to access and visualize the internal diseased areas of the body, to collect tissue samples, and to insert devices that help stop internal bleeding. The equipment is relatively safe and can be used to view parts of the body that are otherw …
  • 自動車用ブレーキライニングの世界市場2019-2023
    Technavio Announces the Publication of its Research Report – Global Automotive Brake Linings Market 2019-2023 Technavio recognizes the following companies as the key players in the global automotive brake linings market: AISIN SEIKI Co., Ltd., AKEBONO BRAKE INDUSTRY CO., LTD., Brembo S.p.A., Continental AG, General Motors, SGL Group. Commenting on the report, an analyst from Technavio’s team said: …
  • 鉄道用車両の世界市場:機関車、地下鉄、モノレール、路面電車、貨車、旅客用コーチ
    The term rolling stock refers to any moving vehicle on railroads. This typically includes locomotives, metros, monorails, trams, freight wagons, and passenger coaches. Passenger transit are the trains, which are used to transport passengers from one place to another. However, cargo transit is a freight train which is used to transport goods or products from one place to another. The rolling stock …
  • Orca Exploration Group Inc.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Orca Exploration Group Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Orca Exploration Group Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
  • 苛性ソーダの世界市場:製造プロセス別(膜セル、隔膜セル、その他)、用途別(有機化学、無機化学、アルミナ、パルプ&紙、石鹸&洗剤、水処理、その他)
    The global caustic soda market was valued at $36.0 billion in 2018 and is projected to reach $55.8 billion by 2026, growing at a CAGR of 5.50% from 2019 to 2026. Caustic soda, also known as sodium hydroxide and lye, is an inorganic compound composed of sodium cations Na+ and hydroxide anions OH−. It is highly caustic base that decomposes proteins at normal room temperature and can cause chemical b …
  • 神経内分泌がん(Neuroendocrine Carcinoma):世界の治験レビュー(2015年上半期版)
    Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Neuroendocrine Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuroendocrine Carcinoma. It includes an overview of the trial num …
  • ネットワーク・フォレンジックス(鑑識)の世界市場予測(~2021)
    The network forensics market size is expected to grow from USD 1.25 Billion in 2016 to USD 2.69 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 16.6% during the forecast period. The major growth drivers of the market include increased need to secure networks from advanced attacks, such as ransomware, Distributed Denial of Service (DDoS), and Advanced Persistent Threats (APTs); increase …
  • アジアの患者診察機器市場見通し(~2021)
    Asia-Pacific Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Patient Examination Devices Market Outlook to 2021", provides key market data on the Asia-Pacific Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes and T …
  • 低脂肪乳飲料の世界市場2018-2022
    About Low-fat Dairy Beverages The report covers the current scenario and estimates the value of the global low-fat dairy beverages market for the forecast period 2018-2022. The parent market for the global low-fat dairy beverages market is the global dairy market. Technavio’s analysts forecast the global low-fat dairy beverages market to grow at a CAGR of 3.45% during the period 2018-2022. Covered …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。